CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Open-market buy CEO & President bought 39,000 shares at $0.14 ($5,382)
- 4 Open-market buy CEO & President bought 31,298 shares at $0.16 ($5,070)
- 4 Open-market buy CEO & President bought 12,751 shares at $0.16 ($2,015)
- 4 Open-market buy CEO & President bought 20,299 shares at $0.16 ($3,167)
- 8-K Event Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- 4 Open-market buy CEO & President bought 31,675 shares at $0.16 ($5,068)
- 4 Open-market buy CEO & President bought 31,250 shares at $0.16 ($5,094)
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy CEO & President bought 24,000 shares at $0.21 ($4,992)
- 4 Open-market buy CEO & President bought 11,000 shares at $0.21 ($2,310)
- 4 Open-market buy CEO & President bought 22,000 shares at $0.22 ($4,862)
- 4 Open-market buy CEO & President bought 5,900 shares at $0.22 ($1,292)
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · Agreement ended · Unregistered share sale
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
Page 1 of 82 · 1,636 filings